Is Merck & Co., Inc. (MRK) the Best Medical Stock to Buy According to Billionaires?

From Yahoo Finance: 2025-04-13 17:57:00

Experts suggest that medical, healthcare, and pharma stocks may be immune from trade turmoil, offering a safe haven during market uncertainty. Healthcare companies are facing challenges due to patent cliffs, pricing degradation, and competition, leading to investor skepticism. Managed care and US-centric medical device stocks are seen as safer bets in this environment. Merck & Co., Inc. (NYSE: MRK) is among the top medical stocks, with strong operations and promising products despite revenue challenges. Analysts are bullish on MRK’s future growth potential, ranking it 8th on the list of best medical stocks to buy now.

GreensKeeper Asset Management highlighted MRK’s short-term challenges but remains optimistic about its long-term prospects, particularly with its Keytruda cancer treatment. While MRK shows promise, some believe AI stocks offer greater potential for higher returns within a shorter timeframe. Consider exploring AI stocks for more promising investment opportunities.



Read more at Yahoo Finance: Is Merck & Co., Inc. (MRK) the Best Medical Stock to Buy According to Billionaires?